CVC/Sebia: Represented CVC Capital Partners in its investment, alongside Téthys Invest, in Sebia, a world-leading provider of technology used for in-vitro diagnostic testing, from Astorg and Montagu Private Equity.
exocad GmbH/The Carlyle Group: Represented the shareholders of exocad GmbH, an independent developer of dental software solutions, in the sale of a majority stake to The Carlyle Group as well as certain shareholders on their reinvestment.
Hansen Medical/Auris Surgical Robots: Advised funds owned by Oracle Management and other majority stockholders of Hansen Medical, Inc. in the acquisition of Hansen Medical by Auris Surgical Robotics, Inc., as well as the related re-investment by such stockholders of their proceeds into Auris.
IK Investment Partners/Marle: Represented IK Investment Partners in its agreement to acquire orthopedic implant manufacturing company Marle from The Carlyle Group.
Kinnser Software/Insight Venture Partners/Mediware: Represented Kinnser Software, Inc., the leading provider of software solutions for home health and hospice providers, and Insight Venture Partners in the sale of Kinnser to TPG Capital-backed Mediware Information Systems, Inc.
PAI Partners/ELITech: Represented PAI Partners in its acquisition of ELITech Group, a leading manufacturer of specialty in-vitro diagnostics equipment and reagents, from Ergon Capital.
Salient CRGT/Information Innovators: Represented Bridge Growth Partners, LLC and Salient CRGT in Salient CRGT’s acquisition of Information Innovators, Inc., a technology and mission-focused company serving the federal government, with particular strength in the healthcare IT arena.
Tornier N.V./Wright Medical Group: Represented Tornier N.V., a designer, manufacturer and marketer of joint replacement devices, in its $3.3 billion merger with Wright Medical Group, Inc.
Valtech Cardio/Edwards Lifesciences Corporation: Represented Valtech Cardio in its acquisition by Edwards Lifesciences Corporation for up to $690 million.
Warburg Pincus: Represented Warbug in a number of significant acquisition-related transactions with the following medical technology companies:
- Accumetrics: Advised Warburg and ITC Nexus Holding Company in the acquisition of Accumetrics, a global leader in assessing patient response to all major antiplatelet therapies.
- Aircast, Inc.: Represented Warburg and Credit Suisse First Boston in connection with investments in this leading global provider.
- Constitutional Medical Inc./Roche Diagnostics: Represented CMI and Warburg in the sale of CMI to Roche Diagnostics.